Director of Bladder, Kidney and Prostate Cancer Treatment @
Healthcare Economist / HEOR @
Director of Urologic Oncology and Robotic Surgery, Board Certified Urologist @
BS/BA Cum Laude @
My goal as a urologist and urologic oncology is to preserve, maintain and improve urological health and quality of life of my patients. I focus on preservation of voiding and renal function in patients with underlying renal insufficiency, risk factors and kidney stones. I utilize risk-stratified approach to managing cancers of the kidneys, bladder and the
My goal as a urologist and urologic oncology is to preserve, maintain and improve urological health and quality of life of my patients. I focus on preservation of voiding and renal function in patients with underlying renal insufficiency, risk factors and kidney stones. I utilize risk-stratified approach to managing cancers of the kidneys, bladder and the prostate.
Specializing in medical and surgical management of diseases of the kidneys, adrenals, ureters, bladder, prostate, the retroperitoneum, and male and female genitalia. Evaluation of urinary incontinence, impotence, overactive bladder, PSA screening.
Expertise in management and evaluation of hematuria, bladder cancer and kidney stones.
Healthcare Economics & Public policy:
Healthcare economics and outcomes research (HEOR) in urology, cost-effectiveness (CEA), comparative effectiveness research (CER) in urology, pharmoeconomics, clinical outcomes research in urology, healthcare related quality of life (HRQOL), patient reported outcomes (PRO), QALY analysis, urology, oncology. Optimization of urological care. Development of study protocols and interpretation of HEOR data analyses.
Specialties: Urology / Oncology
Healthcare Economics HEOR / PRO
Director of Bladder, Kidney and Prostate Cancer Treatment @ Urologist specializing in evaluation and treatment of men and women with blood in urine and kidney, bladder and prostate problems. From September 2013 to Present (2 years 4 months) Greater New York City AreaHealthcare Economist / HEOR @ Expert in healthcare economics and public policy.
Consultant / KOL in Health Economics / Pharmacoeconomics (2011 – Present)
Product Positioning, Pricing, Reimbursement and Market Consulting to pharma, biotech and device manufacturers and investors
- Strategic Advice, Market Strategy, opportunity assessment, market modeling
- Competitive Landscape analysis / product positioning
- Strategic advice design of ROI/Cost Effectiveness studies for sales/reimbursement strategy (Treatment costs, cost of illness, direct and indirect costs), model development, Markov modeling.
- prostate cancer, bladder cancer, renal cancer, nephrolithiasis, overactive bladder and bladder dysfunction, erectile dysfunction and Peyronie's disease, kidney stones. From January 2011 to Present (5 years) Director of Urologic Oncology and Robotic Surgery, Board Certified Urologist @ Board certified, fellowship trained urologic surgeon with interest in cancers of kidneys, bladder, and prostate. Expertise in management of complex urological conditions.
I utilize multimodal treatment including surgical treatment with open and laparascopic and robotic surgery, minimally invasive treatments with cryoablation, HIFU as well as chemotherapy and immunotherapy such as PROVENGE, IL-2 as well as novel targeted molecular and hormonal treatments such as Zytiga, Jevtana, Taxotere, Denosumab, Casodex, Xtandi, and radiopharmaceuticals such as Xofigo.
Mention prostate cancer, bladder cancer.... From July 2010 to Present (5 years 6 months) Urologic Oncology @ Urologic oncology, endourology and general urology. From April 2011 to June 2013 (2 years 3 months) Urology & Urologic Oncology @ Established a modern Urological Service with introduction of new service lines.
Performed first PCNL, first IVC thrombectomy at the hospital. First robotic partial nephrectomy and nephroureterectomy in the group.
Providing urological care to patients with complex urological conditions including medical and surgical treatment of bladder, prostate and kidney problems.
Specified system-wide IT reporting capabilities for Urology to improve productivity and quality of care.
Introduced streamlined order workflow solutions to improve productivity. From 2011 to June 2013 (2 years) Owner @ Strategy: International expansion; vertical and horizontal partnerships; Niche marketing
HR: Employee and contractor recruitment
Marketing: Managed marketing programs: SEO, PPC, program optimization. Development of collateral material.
IT: Software logic specifications and software design, managed GUI design, software feature development; process automation From 2000 to 2011 (11 years) Urologic Oncologist @ Urologic oncologist - treatment of urologic malignancies and benign conditions. From July 2010 to September 2010 (3 months) Fellow in Minimally Invasive Urologic Oncology @ Fellowship in urologic oncology. Evaluation and multimodal treatment of prostate cancer, bladder cancer, testicular and kidney cancers. Application of minimally invasive treatment options to care for appropriately selected urologic cancers including laparoscopy, robotics and endourology. From July 2009 to June 2010 (1 year)
MD, Medicine @ State University of New York Downstate Medical Center College of Medicine From 1999 to 2003 BS/BA Cum Laude, Biology / Economics @ Brandeis University From 1995 to 1999 Alex Shteynshlyuger is skilled in: Oncology, Clinical Development, Pharmaceutical Industry, Public Health, Health Economics, Outcomes Research, Clinical Research, Healthcare, Statistics, Clinical Trials, Internal Medicine, Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma, bladder dysfunction
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension